Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2003-9-22
pubmed:abstractText
Hepatocyte growth factor (HGF) modulates intestinal epithelial cell proliferation and migration, serving as a critical regulator of intestinal wound healing. In this study, we examined the effect of administration of recombinant human HGF on colonic mucosal damage in vivo. Acute colitis was induced in rats by feeding with 5% dextran sulfate sodium (DSS) for 7 days, and colitis was subsequently maintained by feeding with 1% DSS. On the 5th day of DSS administration, osmotic pumps releasing recombinant human HGF (200 microg/day) were implanted into the peritoneum of the rats. Continuous intraperitoneal delivery of HGF led to both increased serum human HGF levels and c-Met tyrosine phosphorylation within the colonic mucosa. Compared with mock-treated rats, those administered human HGF showed a reduction in colitis-associated weight loss, large intestinal shortening, and improved colonic erosions. Enhanced epithelial regeneration and cellular proliferation were observed in rats treated with recombinant human HGF. The weights of the liver, kidneys, and spleen were not affected by HGF administration. These results indicate that HGF administration accelerates colonic mucosal repair in rats with DSS-induced colitis and suggest that recombinant human HGF may be a useful therapeutic tool to facilitate intestinal wound healing in patients with ulcerative colitis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0022-3565
pubmed:author
pubmed:issnType
Print
pubmed:volume
307
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
146-51
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:12954797-Animals, pubmed-meshheading:12954797-Colitis, Ulcerative, pubmed-meshheading:12954797-Colon, pubmed-meshheading:12954797-Dextran Sulfate, pubmed-meshheading:12954797-Disease Models, Animal, pubmed-meshheading:12954797-Hepatocyte Growth Factor, pubmed-meshheading:12954797-Humans, pubmed-meshheading:12954797-Inflammation, pubmed-meshheading:12954797-Infusions, Parenteral, pubmed-meshheading:12954797-Intestinal Mucosa, pubmed-meshheading:12954797-Kidney, pubmed-meshheading:12954797-Liver, pubmed-meshheading:12954797-Organ Size, pubmed-meshheading:12954797-Phosphorylation, pubmed-meshheading:12954797-Proto-Oncogene Proteins c-met, pubmed-meshheading:12954797-Rats, pubmed-meshheading:12954797-Rats, Wistar, pubmed-meshheading:12954797-Recombinant Proteins, pubmed-meshheading:12954797-Spleen, pubmed-meshheading:12954797-Tyrosine, pubmed-meshheading:12954797-Weight Loss, pubmed-meshheading:12954797-Wound Healing
pubmed:year
2003
pubmed:articleTitle
Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats.
pubmed:affiliation
Department of Internal Medicine II, Miyazaki Medical College, Kiyotake, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't